About a dozen years ago, I was interviewing for a job at The Wall Street Journal when I was asked by an editor what I thought would be the most important story in the coming year for the pharmaceutical industry. “Pricing,” I responded immediately.Read the rest…
Want more insights? Join Grow With Caliber - our career elevating newsletter and get our take on the future of work delivered weekly.
